Chapter title |
Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies
|
---|---|
Chapter number | 10 |
Book title |
Histone Deacetylases
|
Published in |
Methods in molecular biology, January 2016
|
DOI | 10.1007/978-1-4939-3667-0_10 |
Pubmed ID | |
Book ISBNs |
978-1-4939-3665-6, 978-1-4939-3667-0
|
Authors |
John Powers, Maritza Lienlaf, Patricio Perez-Villarroel, Susan Deng, Tessa Knox, Alejandro Villagra, Eva Sahakian, Powers, John, Lienlaf, Maritza, Perez-Villarroel, Patricio, Deng, Susan, Knox, Tessa, Villagra, Alejandro, Sahakian, Eva |
Abstract |
Histone deacetylase 10 (HDAC10) belongs to the class IIb HDAC family and its biological role remains mostly unidentified. A decreased HDAC10 expression has been reported in patients with aggressive solid tumors (Osada et al. Int J Cancer 112: 26-32, 2004; Jin et al. Int J Clin Exp Pathol 7: 5872-5879, 2014), suggesting that loss of HDAC10 expression might confer a survival advantage to malignant cells. Consequently, results from our lab suggests that overexpression of HDAC10 in aggressive mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) Z138c and MEC1 cells, respectively, resulted in a rapid induction of cell death in vitro with only 5 % of cells being alive at 48 h, cell cycle arrest, and up-regulation of co-stimulatory molecules. Here we present several standard methods to study the function of HDAC10 in B cell malignancies. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 11 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 27% |
Lecturer | 1 | 9% |
Other | 1 | 9% |
Student > Master | 1 | 9% |
Student > Postgraduate | 1 | 9% |
Other | 0 | 0% |
Unknown | 4 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 36% |
Agricultural and Biological Sciences | 1 | 9% |
Economics, Econometrics and Finance | 1 | 9% |
Design | 1 | 9% |
Unknown | 4 | 36% |